Navigation Links
S14G-humanin is a new hope for Alzheimer's disease
Date:10/30/2013

Humanin is a potential therapeutic agent for Alzheimer's disease, and its derivative, S14G-humanin, is 1 000-fold stronger in its neuroprotective effect against Alzheimer's disease-relevant insults. Al-though effective, the detailed molecular mechanism through which S14G-humanin exerts its effects remains unclear. A recent study by Xue Li and colleagues from Henan Provincial People's Hospital, China investigated the inhibitory effects of S14G-humanin on amyloid-beta protein-induced hippocampal neuronal injury, and data from this study showed that fibrillar amyloid-beta 40 disturbed cellular homeostasis through the cell membrane, increasing intracellular calcium, generating reactive oxygen species, and decreasing the mitochondrial membrane potential. S14G-humanin blocked the effects of amyloid-beta 40 on the neuronal cell membrane, and restored the disturbed cellular homeostasis, thereby exhibiting a potential and effective treatment for Alzheimer's disease. These findings were published in the Neural Regeneration Research (Vol. 8, No. 27, 2013).


'/>"/>

Contact: Meng Zhao
eic@nrren.org
86-138-049-98773
Neural Regeneration Research
Source:Eurekalert  

Page: 1

Related biology news :

1. A new DNA vaccine induces a Th2 immune response in Alzheimers disease mice
2. Untangling Alzheimers disease
3. Rare childhood disease may hold clues to treating Alzheimers and Parkinsons
4. NIH-supported study identifies 11 new Alzheimers disease risk genes
5. Clemson hosting scientists who study devastating diseases
6. Early-life exposure of frogs to herbicide increases mortality from fungal disease
7. Foot and mouth disease in sub-Saharan Africa moves over short distances, wild buffalo are a problem
8. Targeted culling of deer controls disease with little effect on hunting
9. Study explores the role of uncertainty in infectious disease modelling
10. Garvan Institute receives grant to research role of long non-coding RNAs in Parkinsons disease
11. Mild cognitive impairment in Parkinsons disease may be linked with extensive neurodegeneration
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
S14G-humanin is a new hope for Alzheimer's disease
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems ... seamlessly log work hours, for employers to make sure the right employees are actually ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):
(Date:6/22/2016)... 2016 Research and Markets has announced the ... to their offering. The ... $29.3 billion in 2013. The market is expected to grow at ... to 2020, increasing from $50.6 billion in 2015 to $96.6 billion ... the forecast period (2015 to 2020) are discussed. As well, new ...
(Date:6/22/2016)... ... June 22, 2016 , ... ... Center’s Port business incubator and current participant in the Phase 1 Ventures program, ... cancer patients. , Quantitative Radiology Solutions helps physicians make better treatment decisions ...
(Date:6/22/2016)... ... June 22, 2016 , ... The Immigrant Journey ... and contributions to North Texas and the nation, recently held its annual luncheon ... to the civic and economic vitality of North Texas. Proceeds from the event ...
(Date:6/22/2016)... , June 22, 2016 On ... session at 4,843.76, up 0.14%; the Dow Jones Industrial Average ... closed at 2,088.90, up 0.27%. The gains were broad based ... positive. Stock-Callers.com has initiated coverage on the following equities: Minerva ... (NASDAQ: PTLA ), Trevena Inc. (NASDAQ: ...
Breaking Biology Technology: